Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minirin oral lyophilisate versus tablet preference study in children and adolescents with primary nocturnal enuresis
2004-000593-32Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Oct 2004
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of desmopressin in nocturnal enuresis (NE) (2 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Treatment preference. Started Oct 2004; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on 2004-000593-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000593-32.